1. Home
  2. GLU vs ONCY Comparison

GLU vs ONCY Comparison

Compare GLU & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLU
  • ONCY
  • Stock Information
  • Founded
  • GLU 2004
  • ONCY 1998
  • Country
  • GLU United States
  • ONCY Canada
  • Employees
  • GLU N/A
  • ONCY N/A
  • Industry
  • GLU Finance/Investors Services
  • ONCY Pharmaceuticals and Biotechnology
  • Sector
  • GLU Finance
  • ONCY Health Care
  • Exchange
  • GLU Nasdaq
  • ONCY Nasdaq
  • Market Cap
  • GLU 99.4M
  • ONCY 49.1M
  • IPO Year
  • GLU N/A
  • ONCY 1999
  • Fundamental
  • Price
  • GLU $17.65
  • ONCY $1.17
  • Analyst Decision
  • GLU
  • ONCY Strong Buy
  • Analyst Count
  • GLU 0
  • ONCY 4
  • Target Price
  • GLU N/A
  • ONCY $4.33
  • AVG Volume (30 Days)
  • GLU 12.4K
  • ONCY 1.6M
  • Earning Date
  • GLU 01-01-0001
  • ONCY 07-31-2025
  • Dividend Yield
  • GLU 8.60%
  • ONCY N/A
  • EPS Growth
  • GLU N/A
  • ONCY N/A
  • EPS
  • GLU 0.62
  • ONCY N/A
  • Revenue
  • GLU N/A
  • ONCY N/A
  • Revenue This Year
  • GLU N/A
  • ONCY N/A
  • Revenue Next Year
  • GLU N/A
  • ONCY N/A
  • P/E Ratio
  • GLU $22.50
  • ONCY N/A
  • Revenue Growth
  • GLU N/A
  • ONCY N/A
  • 52 Week Low
  • GLU $11.61
  • ONCY $0.33
  • 52 Week High
  • GLU $15.40
  • ONCY $1.53
  • Technical
  • Relative Strength Index (RSI)
  • GLU 68.62
  • ONCY 75.27
  • Support Level
  • GLU $17.38
  • ONCY $0.71
  • Resistance Level
  • GLU $17.77
  • ONCY $1.31
  • Average True Range (ATR)
  • GLU 0.20
  • ONCY 0.12
  • MACD
  • GLU 0.05
  • ONCY 0.04
  • Stochastic Oscillator
  • GLU 100.00
  • ONCY 81.33

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: